Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Patel

Showing results (201-210 of 281) with videos related to

Pageof 29
Sort By:
The American Journal of Medicine|September 22, 2018
Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection FractionEssraa Bayoumi, Phillip H Lam, Daniel J Dooley, et al.
Clinical Kidney Journal|August 4, 2025
Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registryMatthew D Nguyen, Ryan Fekrat, Caroline Gee, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Lancet. Rheumatology|February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' replyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Nature Chemical Biology|May 31, 2016
σ1 receptor ligands control a switch between passive and active threat responsesAndrew J Rennekamp, Xi-Ping Huang, You Wang, et al.
Ophthalmology|January 20, 2019
Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous ChorioretinopathySarah Mrejen, Chandrakumar Balaratnasingam, Talia R Kaden, et al.
Journal of the American College of Radiology : JACR|January 8, 2017
Report of the ACR's Economics Committee on Value-Based Payment ModelsGiles W Boland, Lucille Glenn, Shlomit Goldberg-Stein, et al.
Molecular & Cellular Proteomics : MCP|April 7, 2010
A bimodal distribution of two distinct categories of intrinsically disordered structures with separate functions in FG nucleoporinsJustin Yamada, Joshua L Phillips, Samir Patel, et al.
Blood Purification|February 26, 2018
Association between Heights of Dialysis Patients and Outcomes: Results from a Retrospective Cohort Study of the International MONitoring Dialysis Outcomes (MONDO) Database InitiativeSamir Patel, Alice Topping, Xiaoling Ye, et al.
Pageof 29

Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
The American Journal of Medicine|September 22, 2018
Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection FractionEssraa Bayoumi, Phillip H Lam, Daniel J Dooley, et al.
Clinical Kidney Journal|August 4, 2025
Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registryMatthew D Nguyen, Ryan Fekrat, Caroline Gee, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Lancet. Rheumatology|February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' replyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Nature Chemical Biology|May 31, 2016
σ1 receptor ligands control a switch between passive and active threat responsesAndrew J Rennekamp, Xi-Ping Huang, You Wang, et al.
Ophthalmology|January 20, 2019
Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous ChorioretinopathySarah Mrejen, Chandrakumar Balaratnasingam, Talia R Kaden, et al.
Journal of the American College of Radiology : JACR|January 8, 2017
Report of the ACR's Economics Committee on Value-Based Payment ModelsGiles W Boland, Lucille Glenn, Shlomit Goldberg-Stein, et al.
Molecular & Cellular Proteomics : MCP|April 7, 2010
A bimodal distribution of two distinct categories of intrinsically disordered structures with separate functions in FG nucleoporinsJustin Yamada, Joshua L Phillips, Samir Patel, et al.
Blood Purification|February 26, 2018
Association between Heights of Dialysis Patients and Outcomes: Results from a Retrospective Cohort Study of the International MONitoring Dialysis Outcomes (MONDO) Database InitiativeSamir Patel, Alice Topping, Xiaoling Ye, et al.
Pageof 29